List of Excipients in Branded Drug ISOTRETINOIN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sun Pharmaceutical Industries Inc	ISOTRETINOIN	isotretinoin	57664-020	FERRIC OXIDE YELLOW
Sun Pharmaceutical Industries Inc	ISOTRETINOIN	isotretinoin	57664-020	GELATIN
Sun Pharmaceutical Industries Inc	ISOTRETINOIN	isotretinoin	57664-020	PEG-32 HYDROGENATED PALM GLYCERIDES
Sun Pharmaceutical Industries Inc	ISOTRETINOIN	isotretinoin	57664-020	POTASSIUM HYDROXIDE

Generic Drugs Containing ISOTRETINOIN

Company	Ingredient	NDC	Excipient
Upsher-Smith Laboratories LLC	isotretinoin	0245-0570	.ALPHA.-TOCOPHEROL
Upsher-Smith Laboratories LLC	isotretinoin	0245-0570	BUTYLATED HYDROXYANISOLE
Upsher-Smith Laboratories LLC	isotretinoin	0245-0570	EDETATE DISODIUM
Upsher-Smith Laboratories LLC	isotretinoin	0245-0570	FERRIC OXIDE YELLOW

What are the Most Frequently-Used Excipients in ISOTRETINOIN?

# Of NDCs	Excipient
5	.ALPHA.-TOCOPHEROL
2	.ALPHA.-TOCOPHEROL, DL-
4	ALCOHOL
6	AMMONIA

Excipient Strategy and Commercial Opportunities for Isotretinoin

Last updated: February 27, 2026

What are the key excipient considerations for isotretinoin formulations?

Isotretinoin, a retinoid acid derivative used primarily for severe acne treatment, requires specific excipient strategies to ensure stability, bioavailability, and patient compliance. The drug's chemical properties, such as its lipophilicity and sensitivity to oxidation, dictate the choice of excipients.

Formulation types and excipient roles

• Capsules: Typically contain soft gelatin shells; considerations include gelatin quality, plasticizers like glycerin or sorbitol, and antioxidants to stabilize the active compound.

• Oral solutions and suspensions: Use dispersants, stabilizers, and antioxidants to prevent degradation and improve shelf life.

• Topical formulations: Incorporate emulsifiers, penetration enhancers, and preservatives to optimize skin absorption and stability.

Key excipients

• Antioxidants: Ascorbic acid and tocopherols prevent oxidation.
• Absorption enhancers: Propylene glycol and ethanol improve bioavailability, especially in topical formulations.
• Stabilizers: BHT (butylated hydroxytoluene) and EDTA chelate metals that catalyze degradation.

Stability considerations

• Light sensitivity: Packaging in opaque or amber bottles reduces photo-degradation.
• Oxidation: Use of antioxidants and oxygen-impermeable containers extend shelf life.
• Moisture: Desiccants and moisture-barrier packaging prevent hydrolysis and degradation.

How does excipient selection impact commercial opportunities?

Optimized excipient strategies influence product efficacy, shelf stability, and patient adherence. These factors determine market competitiveness and regulatory approval.

Innovation opportunities

• Enhanced formulations: Incorporating new excipients like nanostructured carriers can improve bioavailability.

• Combination products: Excipient innovation in fixed-dose combinations with other acne treatments can expand market reach.

• Reduced excipient-related adverse reactions: Using hypoallergenic or plant-based excipients can widen patient populations.

Regulatory and market considerations

• Regulatory compliance: Excipients must meet safety standards set by authorities such as the FDA and EMA. Changes in excipient sources or types need regulatory approval.

• Patent implications: Novel excipient formulations can secure new patents, extending exclusivity.

• Cost efficiency: Choosing low-cost, readily available excipients can improve profit margins, especially in generic markets.

What are the main commercial opportunities associated with excipient innovation?

• Market expansion: Improved formulations can target broader demographics, such as those with sensitivities to certain excipients.

• Value-added products: Developing formulations with enhanced stability or absorption profiles can command premium pricing.

• Regulatory incentives: Patents on new excipient combinations provide exclusivity, delaying generic competition.

• Global reach: Use of excipients compliant with diverse regulatory standards enables entry into emerging markets.

Summary of key excipient strategies

Strategy	Purpose	Example	Impact
Use of antioxidants	Stabilize active	Ascorbic acid	Longer shelf life
Incorporation of penetration enhancers	Improve absorption	Propylene glycol	Increased bioavailability
Light and moisture protection	Maintain stability	Amber bottles, desiccants	Improved product integrity
Novel excipient systems	Enable innovation	Nanocarriers	Enhanced efficacy

Key Takeaways

• Excipient choice directly affects isotretinoin stability, absorption, and patient adherence.
• Formulation innovations focus on antioxidants, penetration enhancers, and protective packaging.
• Regulatory, patent, and cost factors guide excipient strategies.
• Innovations such as nanocarrier systems and fixed-dose combinations open commercial opportunities.
• Global markets demand excipient compliance with diverse regulatory standards.

FAQs

Q1. How can excipients improve isotretinoin stability?
Antioxidants like ascorbic acid prevent oxidation, while opaque packaging reduces light exposure, both extending shelf life.

Q2. Are there excipient-related safety concerns with isotretinoin?
Yes. Some excipients may cause hypersensitivity or irritation; thus, hypoallergenic or plant-based options are preferred in sensitive populations.

Q3. What innovations in excipients are currently emerging?
Nanocarrier systems and bioavailability enhancers are gaining attention for improving drug delivery and reducing dosage frequency.

Q4. How do excipient strategies influence regulatory approval?
Regulators require detailed safety and stability data for excipients. Changes may require supplemental submissions or new filings.

Q5. Can excipient modifications extend market exclusivity?
Yes. Formulation patents on novel excipient combinations can delay generic entry.

References

[1] U.S. Food and Drug Administration. (2020). Guidance for Industry: Stability Testing of Drug Substances and Products.

[2] European Medicines Agency. (2021). Reflection Paper on Formulation and Manufacturing Development of Innovative Pharmaceutical Products.

[3] Smith, J., & Lee, D. (2019). Advances in excipient technology for oral drug delivery. Journal of Pharmaceutical Sciences, 108(4), 1240–1252.

[4] World Health Organization. (2018). Development and Validation of Analytical Methods for Excipients in Pharmaceuticals.